Acanthamoeba Keratitis Successfully Treated Medically
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Confocal Microscopy in Cornea Guttata and Fuchs' Endothelial Dystrophy
Br J Ophthalmol 1999;83:185–189 185 Confocal microscopy in cornea guttata and Fuchs’ Br J Ophthalmol: first published as 10.1136/bjo.83.2.185 on 1 February 1999. Downloaded from endothelial dystrophy Auguste G-Y Chiou, Stephen C Kaufman, Roger W Beuerman, Toshihiko Ohta, Hisham Soliman, Herbert E Kaufman Abstract conventional imaging methods.3–13 Because of Aims—To report the appearances of cor- its ability to focus the light source and the nea guttata and Fuchs’ endothelial dystro- image on the same focal plane, it allows real phy from white light confocal microscopy. time in vivo assessment of the diVerent layers Methods—Seven eyes of four consecutive of the cornea, including the endothelial layer. patients with cornea guttata were pro- Therefore, it may be an alternative method in spectively examined. Of the seven eyes, evaluating cornea guttata or Fuchs’ endothelial three also had corneal oedema (Fuchs’ dystrophy. dystrophy). In vivo white light tandem In the current study, we analysed the scanning confocal microscopy was per- appearances of cornea guttata and Fuchs’ dys- formed in all eyes. Results were compared trophy from confocal microscopy and compare with non-contact specular microscopy. the technique with non-contact specular mi- Results—Specular microscopy was pre- croscopy. cluded by corneal oedema in one eye. In the remaining six eyes, it demonstrated typical changes including pleomorphism, polymegathism, and the presence of gut- tae appearing as dark bodies, some with a central bright reflex. In all seven eyes, confocal microscopy revealed the pres- ence of round hyporeflective images with an occasional central highlight at the level of the endothelium. -
Full Text in Pdf Format
DISEASES OF AQUATIC ORGANISMS Published July 30 Dis Aquat Org Oral pharmacological treatments for parasitic diseases of rainbow trout Oncorhynchus mykiss. 11: Gyrodactylus sp. J. L. Tojo*, M. T. Santamarina Department of Microbiology and Parasitology, Laboratory of Parasitology, Faculty of Pharmacy, Universidad de Santiago de Compostela, E-15706 Santiago de Compostela, Spain ABSTRACT: A total of 24 drugs were evaluated as regards their efficacy for oral treatment of gyro- dactylosis in rainbow trout Oncorhj~nchusmykiss. In preliminary trials, all drugs were supplied to infected fish at 40 g per kg of feed for 10 d. Twenty-two of the drugs tested (aminosidine, amprolium, benznidazole, b~thionol,chloroquine, diethylcarbamazine, flubendazole, levamisole, mebendazole, n~etronidazole,mclosamide, nitroxynil, oxibendazole, parbendazole, piperazine, praziquantel, roni- dazole, secnidazole, tetramisole, thiophanate, toltrazuril and trichlorfon) were ineffective Triclabenda- zole and nitroscanate completely eliminated the infection. Triclabendazole was effective only at the screening dosage (40 g per kg of feed for 10 d), while nitroscanate was effective at dosages as low as 0.6 g per kg of feed for 1 d. KEY WORDS: Gyrodactylosis . Rainbow trout Treatment. Drugs INTRODUCTION to the hooks of the opisthohaptor or to ulceration as a result of feeding by the parasite. The latter is the most The monogenean genus Gyrodactylus is widespread, serious. though some individual species have a restricted distri- Transmission takes place largely as a result of direct bution. Gyrodactyloses affect numerous freshwater contact between live fishes, though other pathways species including salmonids, cyprinids and ornamen- (contact between a live fish and a dead fish, or with tal fishes, as well as marine fishes including gadids, free-living parasites present in the substrate, or with pleuronectids and gobiids. -
Benznidazole(Rinn)
830 Antiprotozoals Uses and Administration in endemic areas. It may also be used for prophylaxis in non- Neth.: Wellvone; Port.: Wellvone; S.Afr.: Wellvone; Spain: Wellvone; Atovaquone is a hydroxynaphthoquinone antiprotozo- immune travellers9,10 and appears to be well tolerated.10,11 Swed.: Wellvone; Switz.: Wellvone; UK: Wellvone; USA: Mepron. 1. Chiodini PL, et al. Evaluation of atovaquone in the treatment of Multi-ingredient: Austral.: Malarone; Austria: Malarone; Promal; Belg.: al that is also active against the fungus Pneumocystis patients with uncomplicated Plasmodium falciparum malaria. J Malarone; Canad.: Malarone; Cz.: Malarone; Denm.: Malarone; Fr.: Ma- jirovecii. It is used in the treatment and prophylaxis of Antimicrob Chemother 1995; 36; 1073–5. larone; Ger.: Malarone; Gr.: Malarone; Hong Kong: Malarone; Hung.: Ma- larone; Irl.: Malarone; Israel: Malarone; Ital.: Malarone; Malaysia: Malar- pneumocystis pneumonia in patients unable to tolerate 2. Looareesuwan S, et al. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of one; Neth.: Malarone; Norw.: Malarone; NZ: Malarone; Pol.: Malarone; co-trimoxazole, and with proguanil in the treatment acute uncomplicated malaria in Thailand. Am J Trop Med Hyg S.Afr.: Malanil; Singapore: Malarone; Spain: Malarone; Swed.: Malarone; Switz.: Malarone; UK: Malarone; USA: Malarone. and prophylaxis of malaria. 1996; 54: 62–6. 3. Radloff PD, et al. Atovaquone and proguanil for Plasmodium In the treatment of mild to moderate pneumocystis falciparum malaria. Lancet 1996; 347: 1511–14. pneumonia, atovaquone is given orally in a dose of 4. Sabchareon A, et al. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Azanidazole (BAN, USAN, rINN) 750 mg with food twice daily as a suspension, for 21 Plasmodium falciparum malaria. -
Antiseptics and Disinfectants for the Treatment Of
Verstraelen et al. BMC Infectious Diseases 2012, 12:148 http://www.biomedcentral.com/1471-2334/12/148 RESEARCH ARTICLE Open Access Antiseptics and disinfectants for the treatment of bacterial vaginosis: A systematic review Hans Verstraelen1*, Rita Verhelst2, Kristien Roelens1 and Marleen Temmerman1,2 Abstract Background: The study objective was to assess the available data on efficacy and tolerability of antiseptics and disinfectants in treating bacterial vaginosis (BV). Methods: A systematic search was conducted by consulting PubMed (1966-2010), CINAHL (1982-2010), IPA (1970- 2010), and the Cochrane CENTRAL databases. Clinical trials were searched for by the generic names of all antiseptics and disinfectants listed in the Anatomical Therapeutic Chemical (ATC) Classification System under the code D08A. Clinical trials were considered eligible if the efficacy of antiseptics and disinfectants in the treatment of BV was assessed in comparison to placebo or standard antibiotic treatment with metronidazole or clindamycin and if diagnosis of BV relied on standard criteria such as Amsel’s and Nugent’s criteria. Results: A total of 262 articles were found, of which 15 reports on clinical trials were assessed. Of these, four randomised controlled trials (RCTs) were withheld from analysis. Reasons for exclusion were primarily the lack of standard criteria to diagnose BV or to assess cure, and control treatment not involving placebo or standard antibiotic treatment. Risk of bias for the included studies was assessed with the Cochrane Collaboration’s tool for assessing risk of bias. Three studies showed non-inferiority of chlorhexidine and polyhexamethylene biguanide compared to metronidazole or clindamycin. One RCT found that a single vaginal douche with hydrogen peroxide was slightly, though significantly less effective than a single oral dose of metronidazole. -
Reseptregisteret 2013–2017 the Norwegian Prescription Database
LEGEMIDDELSTATISTIKK 2018:2 Reseptregisteret 2013–2017 Tema: Legemidler og eldre The Norwegian Prescription Database 2013–2017 Topic: Drug use in the elderly Reseptregisteret 2013–2017 Tema: Legemidler og eldre The Norwegian Prescription Database 2013–2017 Topic: Drug use in the elderly Christian Berg Hege Salvesen Blix Olaug Fenne Kari Furu Vidar Hjellvik Kari Jansdotter Husabø Irene Litleskare Marit Rønning Solveig Sakshaug Randi Selmer Anne-Johanne Søgaard Sissel Torheim Utgitt av Folkehelseinstituttet/Published by Norwegian Institute of Public Health Område for Helsedata og digitalisering Avdeling for Legemiddelstatistikk Juni 2018 Tittel/Title: Legemiddelstatistikk 2018:2 Reseptregisteret 2013–2017 / The Norwegian Prescription Database 2013–2017 Forfattere/Authors: Christian Berg, redaktør/editor Hege Salvesen Blix Olaug Fenne Kari Furu Vidar Hjellvik Kari Jansdotter Husabø Irene Litleskare Marit Rønning Solveig Sakshaug Randi Selmer Anne-Johanne Søgaard Sissel Torheim Acknowledgement: Julie D. W. Johansen (English text) Bestilling/Order: Rapporten kan lastes ned som pdf på Folkehelseinstituttets nettsider: www.fhi.no The report can be downloaded from www.fhi.no Grafisk design omslag: Fete Typer Ombrekking: Houston911 Kontaktinformasjon/Contact information: Folkehelseinstituttet/Norwegian Institute of Public Health Postboks 222 Skøyen N-0213 Oslo Tel: +47 21 07 70 00 ISSN: 1890-9647 ISBN: 978-82-8082-926-9 Sitering/Citation: Berg, C (red), Reseptregisteret 2013–2017 [The Norwegian Prescription Database 2013–2017] Legemiddelstatistikk 2018:2, Oslo, Norge: Folkehelseinstituttet, 2018. Tidligere utgaver / Previous editions: 2008: Reseptregisteret 2004–2007 / The Norwegian Prescription Database 2004–2007 2009: Legemiddelstatistikk 2009:2: Reseptregisteret 2004–2008 / The Norwegian Prescription Database 2004–2008 2010: Legemiddelstatistikk 2010:2: Reseptregisteret 2005–2009. Tema: Vanedannende legemidler / The Norwegian Prescription Database 2005–2009. -
Fusarium Keratitis and Corneal Collagen Cross
FUSARIUM KERATITIS AND SURGERY REFRACTIVE CORNEAL COLLAGEN CROSS-LINKING BY MINAS CORONEO, AO, BSC(MED), MBBS, MSC SYD, MD, MS, UNSW, FRACS, FRANZCO; RAJESH FOGLA, DNB, FRCS(EDIN), MMED(OPHTH); WILLIAM B. TRATTLER, MD; ASHIYANA NARIANI, MD, MPH; COMPLEX CASE MANAGEMENT COMPLEX GARGI KHARE VORA, MD; AND ALAN N. CARLSON, MD CASE PRESENTATION A 42-year-old white man is referred to the Duke University Eye Center Cornea Service for a central corneal ulcer with a hypopyon in his right eye. The patient sustained the ocular injury while mowing the lawn, with debris getting into the eye while he was wearing contact lenses. He was diagnosed with culture-positive Fusarium species by the referring ophthalmologist and was treat- ed with oral voriconazole 200 mg twice daily and frequent topical natamycin 5% and voriconazole 10 mg/mL. The patient under- went epithelium-off corneal collagen cross-linking (CXL) approxi- Figure 1. Initial evaluation of the eye with a Fusarium corneal mately 4 weeks after diagnosis of the ulcer and was treated with infiltrate and hypopyon. a loteprednol steroid taper after the procedure. His condition subsequently progressed, with increasing eye pain, a nonhealing epithelial defect, and a worsening corneal infiltrate. Upon evaluation, the patient has a large corneal infiltrate with necrotic stroma, which is approaching the limbus, and a hypopyon (Figure 1). His UCVA measures 20/70-1. B-scan ultrasound of the right eye shows no evidence of posterior segment involvement. Reculturing of the corneal infiltrate is negative for bacteria, fungus, and Acanthamoeba. Confocal microscopy reveals no evidence of hyphae or cysts. -
Simultaneous Determination of Some Antiprotozoal Drugs in Different
Abdelaleem and Abdelwahab Chemistry Central Journal 2012, 6:27 http://journal.chemistrycentral.com/content/6/1/27 RESEARCHARTICLE Open Access Simultaneous determination of some antiprotozoal drugs in different combined dosage forms by mean centering of ratio spectra and multivariate calibration with model updating methods Eglal A Abdelaleem and Nada S Abdelwahab* Abstract Background: Metronidazole (MET) and Diloxanide Furoate (DF), act as antiprotozoal drugs, in their ternary mixtures with Mebeverine HCl (MEH), an effective antispasmodic drug. This work concerns with the development and validation of two simple, specific and cost effective methods mainly for simultaneous determination of the proposed ternary mixture. In addition, the developed multivariate calibration model has been updated to determine Metronidazole benzoate (METB) in its binary mixture with DF in Dimetrol® suspension. Results: Method (I) is the mean centering of ratio spectra spectrophotometric method (MCR) that depends on using the mean centered ratio spectra in two successive steps that eliminates the derivative steps and therefore the signal to noise ratio is enhanced. The developed MCR method has been successfully applied for determination of MET, DF and MEH in different laboratory prepared mixtures and in tablets. Method (II) is the partial least square (PLS) multivariate calibration method that has been optimized for determination of MET, DF and MEH in Dimetrol ® tablets and by updating the developed model, it has been successfully used for prediction of binary mixtures of DF and Metronidazole Benzoate ester (METB) in Dimetrol ® suspension with good accuracy and precision without reconstruction of the calibration set. Conclusion: The developed methods have been validated; accuracy, precision and specificity were found to be within the acceptable limits. -
The Nitroimidazole Family of Drugs
Br J Vener Dis: first published as 10.1136/sti.54.2.69 on 1 April 1978. Downloaded from British Journal of Venereal Diseases, 1978, 54, 69-71 Editorial The nitroimidazole family of drugs In 1955 an antibiotic complex isolated from a operative infection caused by susceptible anaerobes, strain of Streptomyces on the island of Reunion particularly in gynaecological surgery, appendi- was found by research workers of Rhone-Poulenc in cectomy, and colonic surgery. Paris to contain a trichomonacidal antibiotic- Real innovations in chemotherapy, such as azomycin. It had previously been isolated in Japan metronidazole, always attract attention from other (Maeda et al., 1953) and identified as 2-nitroimi- research groups. Although interest was slow to dazole (Ia see Table) (Nakamura, 1955). At the develop, research workers have sought analogous, time, and for some years after, this remarkably structurally-modified compounds which might afford simple compound defied synthesis, but it stimulated some advantage in clinical use-for example, the workers at Rhone-Poulenc to prepare and test greater potency, better tolerance and freedom from the activity of the more readily accessible isomeric side effects, a broader spectrum of action, a longer 5-nitroimidazoles (II). It was their good fortune in duration of action, or in some other characteristic. 1957 to find that these isomers were more active This effort has been concerned with important antiprotozoal agents than the natural product veterinary uses of 5-nitroimidazoles as well as the (Cosar and Julou, 1959). In a series of 150 related applications in human medicine. compounds, the one with a P-hydroxyethyl group Metronidazole has been a difficult target to in the 1-position gave the best compromise between improve upon, but several other drugs of this activity and toxicity and this brand of metroni- chemical family have been introduced to clinical dazole was introduced as Flagyl. -
Reactive Uveitis, Retinal Vasculitis and Scleritis As Ocular End-Stage of Acanthamoeba Keratitis: a Histological Study
Uveitis and vasculitis of Acanthamoeba keratitis ·Brief Report· Reactive uveitis, retinal vasculitis and scleritis as ocular end-stage of Acanthamoeba keratitis: a histological study Lei Shi1,2, Tobias Hager1, Fabian Norbert Fries1, Loay Daas1, Leonard Holbach3, Carmen Hofmann- Rummelt3, Elena Zemova1, Berthold Seitz1, Nóra Szentmáry1,4 1Department of Ophthalmology, Saarland University Medical wearers. Its annual incidence was 17.53 to 21.14 per one Center, Homburg/Saar 66424, Germany million contact lens wearers in the UK[1]. In Germany, with 2Department of Ophthalmology, The First Affiliated Hospital about 80 million inhabitants, about 150 new cases have been of USTC, Division of Life Sciences and Medicine, University reported in a 10-year-period[2]. Studies showed that 68%-92.3% of Science and Technology of China, Hefei 230001, Anhui of AK patients are contact lens wearers[1,3-4]. Expression of Province, P.R. China mannosilated glycoproteins on corneal epithelial cell surface is 3Department of Ophthalmology, Friedrich-Alexander upregulated in contact lens wearers[3]. This plays an important University Erlangen-Nürnberg, Erlangen 91052, Germany role in AK pathogenesis. The Acanthamoeba trophozoite binds 4Department of Ophthalmology, Semmelweis University, to these proteins though its mannose-binding site in order to Budapest 1093, Hungary release the so-called mannose-induced protease 133 (MIP-133) Correspondence to: Lei Shi. Department of Ophthalmology, and Acanthamoeba plasminogen activator (aPA). MIP-133 and Saarland University Medical Center, Homburg/Saar, Kirrberger aPA give rise to lysis of epithelial, stromal cells and stromal Str. 100. 66424, Germany. [email protected] matrix, leading to corneal erosions and ulceration[4]. Presence Received: 2019-05-01 Accepted: 2019-08-21 of bacteria or fungi also supports Acanthamoeba growth, often resulting in co-infection[5]. -
Acanthamoeba, Fungal, and Bacterial Keratitis: a Comparison of Risk Factors and Clinical Features
Acanthamoeba, Fungal, and Bacterial Keratitis: A Comparison of Risk Factors and Clinical Features JEENA MASCARENHAS, PRAJNA LALITHA, N. VENKATESH PRAJNA, MUTHIAH SRINIVASAN, MANORANJAN DAS, SEAN S. D’SILVA, CATHERINE E. OLDENBURG, DURGA S. BORKAR, ELIZABETH J. ESTERBERG, THOMAS M. LIETMAN, AND JEREMY D. KEENAN PURPOSE: To determine risk factors and clinical signs acanthamoeba keratitis research has been conducted in that may differentiate between bacterial, fungal, and industrialized countries, acanthamoeba keratitis also acanthamoeba keratitis among patients presenting with occurs in developing countries, often in non–contact presumed infectious keratitis. lens–wearing individuals.6,7 DESIGN: Hospital-based cross-sectional study. Acanthamoeba keratitis is frequently misdiagnosed as METHODS: We examined the medical records of 115 herpetic or fungal keratitis, and is subsequently treated incor- patients with laboratory-proven bacterial keratitis, 115 rectly, which can lead to poor outcomes.8 Case series of acan- patients with laboratory-proven fungal keratitis, and thamoeba keratitis have identified several important clinical 115 patients with laboratory-proven acanthamoeba kera- signs, such as pseudodendrites, perineural infiltrates, and ring titis seen at Aravind Eye Hospital, Madurai, India, from infiltrates.9,10 However, we are unaware of any studies that 2006-2011. Risk factors and clinical features of the 3 have compared the clinical findings of acanthamoeba organisms were compared using multinomial logistic keratitis with those of bacterial and fungal keratitis. regression. Clinical signs can be especially useful for differentiating the RESULTS: Of 95 patients with bacterial keratitis, 103 cause of infectious keratitis when microbiological testing is patients with fungal keratitis, and 93 patients with acan- not available—which is frequently the case in developing thamoeba keratitis who had medical records available for countries. -
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01 -
(RGP) Contact Lens Induced Microbial Keratitis in a Keratoconus Patient: a Case Report
IOSR Journal of Dental and Medical Sciences (JDMS) ISSN: 2279-0853, ISBN: 2279-0861. Volume 1, Issue 5 (Sep-Oct. 2012), PP 12-16 www.iosrjournals.org Rigid Gas permeable (RGP) contact lens induced microbial keratitis in a keratoconus patient: A case report. Krishnendu Mandal. M.OPT1, Bhupesh Bagga. FRCS2, 3 Sobia Taureen. B. OPT 1,3 Optometry, L.V.Prasad Eye Institute, india 2Ophthalmology, L.V.Prasad Eye Institute, india ABSTRACT : Introduction: To report a case of microbial keratitis in an individual with keratoconus using rigid gas permeable contact lenses. Method: - A 23- year-old male presented with a history of pain, redness, photophobia, watering in right eye and his vision was reduced upon awakening. He was a known case of bilateral keratoconus who used rigid gas permeable contact lenses in both eyes on daily wear basis. Slitlamp examination revealed a paracentral stromal infiltrate in right eye. Corneal scrapings were collected for culture. Both contact lenses and lenses cleaning solution were collected for microbiological investigations. Result: - Corneal scraping revealed plenty gram-negative bacteria (Pseudomonas aeruginosa) and contact lenses cleaning solution revealed klebsiella. Conclusion:- Although microbial keratitis is an uncommon complication with rigid gas permeable contact lenses in keratoconus patients but it can be managed by proper microbiological work up and intensive medical care. Key words:KC-Keratoconus, RGP- rigid gas permeable contact lens, MK-Microbial keratitis, Pseudomonas aeruginosa, Klebsiella. I. Introduction